Home » Topics » Regulatory

Regulatory
RSS

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

Rhone-Poulenc Rorer submits sNDA for new Tilade formulation

Oct. 25, 1996

Rhone-Poulenc Rorer seeks to extend use of antiallergic agent to young children

Oct. 25, 1996

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

First and only Estrophasic oral contraceptive approved

Oct. 18, 1996

Serono's recombinant human growth hormone approved

Oct. 18, 1996

First low-dose hydrochlorothiazide product approvable

Oct. 18, 1996

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...